High response rate in phase I/II paediatric brain cancer trial
A high response rate with a single drug in a phase I/II trial of paediatric brain tumour has set the stage for combination therapy with higher response and lower toxicity, researchers reported at the ESMO 2016 Congress in ...
Oct 7, 2016
0
9